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Abstract
Smooth muscle cells (SMCs) express a unique set of microRNAs (miRNAs) which regulate and maintain the differentiation
state of SMCs. The goal of this study was to investigate the role of miRNAs during the development of gastrointestinal (GI)
SMCs in a transgenic animal model. We generated SMC-specific Dicer null animals that express the reporter, green
fluorescence protein, in a SMC-specific manner. SMC-specific knockout of Dicer prevented SMC miRNA biogenesis, causing
dramatic changes in phenotype, function, and global gene expression in SMCs: the mutant mice developed severe dilation
of the intestinal tract associated with the thinning and destruction of the smooth muscle (SM) layers; contractile motility in
the mutant intestine was dramatically decreased; and SM contractile genes and transcriptional regulators were extensively
down-regulated in the mutant SMCs. Profiling and bioinformatic analyses showed that SMC phenotype is regulated by a
complex network of positive and negative feedback by SMC miRNAs, serum response factor (SRF), and other transcriptional
factors. Taken together, our data suggest that SMC miRNAs are required for the development and survival of SMCs in the GI
tract.
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Introduction
Dicer is a key endonuclease in the RNA interference machinery
that cleaves precursor microRNAs (miRNAs) into mature
miRNAs during miRNA biogenesis [1,2]. MicroRNAs are post-
transcriptional regulators that play critical roles in animal
development. Tissue or cell-specific knockout studies of Dicer have
been performed to uncover the functions of miRNAs during the
development of cells including embryonic stem cells [3], female
germline cells [4], testis Sertoli cells [5], pancreatic islet cells [6],
lung epithelial cells [7], and skeletal chondrocytes [8]. These
studies show that miRNAs are essential in cell proliferation and/or
differentiation during development.
Smooth muscle cells (SMCs), which provide motor activity in
the blood vessels, airways, the bladder, urinary tract, and
gastrointestinal (GI) tract, exhibit remarkable phenotypic plasticity
in congenital or acquired pathological conditions [9,10]. Pheno-
typic changes in SMCs result from substantial changes in gene
expression driven largely by serum response factor (SRF) [10–14].
SRF acts as a master switch for the expression of contractile and
cytoskeletal genes in virtually all cells across diverse species [15].
The activity of SRF is regulated through interactions with
transcriptional co-activators such as myocardin, the myocardin
family members MRTFA and MRTFB [16,17], as well as co-
repressors such as ELK1 [18], NF-kB [19], and HERP1 [20].
During SMC differentiation, SRF regulation is achieved by a
CArG [CC (A/T)6 GG] box found principally in the promoter
and intronic regions of virtually all SM-restricted genes [12,13].
SRF binds to the CArG box, which then transcriptionally activates
or represses SM genes, depending on its associated cofactors.
Recent studies have shown that miRNAs are able to regulate
SMC proliferation and/or differentiation. A set of miRNAs
including miR-21, miR-133a, miR-143, and miR-145 have been
identified as regulators of SMC growth and/or differentiation in
cardiovascular disorders [21–25]. Interestingly, some of these SM
miRNAs are known to be regulated by SRF through conserved
CArG boxes [22,24,25].
We have previously identified GI SM miRNA transcriptomes
from mice and humans which are highly conserved in both
organisms [26]. The SM miRNA transcriptomes consist of several
hundreds of unique miRNAs which comprise almost half of the
entire 701 miRNAs in the miRBase registry [27]. We found that
SMC differentiation and proliferation are modulated by SRF-
dependent, SMC-phenotypic miRNAs. These findings suggest that
SMC miRNAs play an important role during the development of
SMCs in the GI tract. Vascular smooth muscle (VSM)-specific
Dicer-null mice have shown dilated, thin-walled blood vessels that
were affected by a reduction in SMC proliferation [28].
Here we show how the loss of miRNAs affects GISMC phenotype
in the SMC-specific Dicer null animal. These mice display severe
morphological, functional, and genetic defects in GI SMCs, which as
a whole present the features of the chronic intestinal pseudo-
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Intestinal hypoperistalsis syndrome (MMIHS). Both CIPO and
MMIHS are characterized by a dilated intestine with air-fluid levels
as well as impaired intestinal motility in the absence of a mechanical
obstruction [29,30]. Here we propose a model for the regulation of
SMC phenotype by a complex network of indirect and direct positive
and negative feedback loops by SM miRNAs, SRF, and additional
transcriptional factors. This model provides new insight into the
interaction between miRNAs and their target genes in SMCs during
development, and therefore provides a new basis for understanding
the development of GI disorders based on muscle myopathy.
Materials and Methods
For details, see Text S1 for extended Materials and Methods.
Generation of smDicer mutant mice
SMC-specific Dicer null smDicer
2/2;Cre-GFP/+ (smDicer mutant)
mice were generated by cross-breeding a smMHC/Cre/eGFP
(smMHC
Cre-GFP/+) male mouse (gift from Kotlikoff M.I. at Cornell
University) [31] and a Dicer
lox/lox female homozygote mouse (The
Jackson Laboratory) according to a procedure approved by the
Institutional Animal Care and Use Committee at the University of
Nevada, Reno.
Tissue preparation
The smDicer mutant, wild type (WT) smMHC
Cre-GFP/+,o r
C57BL6 mice were anesthetized by isoflurane inhalation and
euthanized by decapitation at the age of ,3 weeks. Multiple
tissues were dissected from the mice. The GI tissues were stripped
free of mucosa and submucous plexus. The multiple tissues were
used for the isolation of total RNAs. Some of the small intestinal
and colonic muscularis tissues were used for Western blots or
purification of SMCs using flow cytometry and fluorescence-
activated cell sorter (FACS). Small intestinal muscularis from ,3-
weeks-old C57BL6 mice were used for organ culture. The GI
tissues were used for microscopic histological analysis or for
mechanical response studies.
Isolation of total and small RNAs from tissues and cells
Total RNAs and/or small RNAs were isolated from multiple
tissues and sorted SMCs from the smDicer mutant and the WT
control mice using the mirVanaTM miRNA isolation kit (Ambion)
as described [32].
RT-PCR and qPCR detection of messenger and small
RNAs
Preparation of the cDNA libraries from the total RNAs isolated
from multiple tissues and from sorted SMCs obtained by FACS, as
well as qPCR analysis on cDNAs, were performed as described
[33]. Preparation of the small RNA cDNA (srcDNA) libraries
obtained from the small RNAs isolated from small intestine tissues
and from SMCs sorted by FACS, as well as qPCR analysis on
srcDNAs, were performed as described [34]. All primers used for
RT-PCR and qPCR are shown in Table S1.
Western blot analysis
SRF and ACTA2 (SM a-actin) expression in the small
intestinal and colonic tissues from the smDicer mutant and the
WT control mice were analyzed by Western blot as described
[26]. The expression level of ACTA2 and SRF was normalized
by GAPDH.
Confocal microscopy and histological analysis
Enhanced green fluorescent protein (eGFP) fluorescence
microscopic analysis of the small intestine, cecum, and colon was
performed as described [35]. For histological analysis, colonic
tissues from the smDicer mutant and the WT control mice were
dehydrated, embedded in paraffin, cut into 6 mm-thick coronal
sections, rehydrated, and stained with hematoxylin and eosin (H &
E). Images were collected using the Zeiss confocal microscope.
Flow cytometry and fluorescence-activated cell sorting
Single cell suspensions from small intestinal and colonic
muscularis dissected from the smDicer mutant and the WT control
mice were prepared as described [35]. Cells were analyzed and
sorted (130 mm nozzle, 12 psi) on a Becton Dickinson FACSAria II
(Becton Dickinson). FlowJo software (Tree Star) was used to
analyze the data. Sorted cells were used for the isolation of total
and small RNAs.
GeneChip arrays for messenger RNAs
Mouse mRNA microarrays were performed on GeneChipH
Mouse Genome 430 2.0 Arrays (Affymetrix) covering 39,000
mouse gene transcripts and variants. About 2 mg of total RNAs
isolated from the small intestinal smooth muscles of the smDicer
mutant and the WT control mice (2 each) were used for the arrays.
The cDNA synthesis, hybridization, cDNA labeling, and scanning
were performed at the Nevada Genomic Center (Reno). Array
data were analyzed by Phalanx Biotech Group (Palo Alto) using
Omicsoft Array Studio software and normalized using the RMA
algorithm. Analyzed array datasets were deposited at the NCBI
Gene Expression Omnibus (GEO) (GSE21738).
Analysis of mechanical response
Small intestine and proximal coloic tissues (10 mm) from the
smDicer mutant and WT control mice were fixed at one end and
attached to a Fort 10 isometric force transducer (WPI). Isometric
force was measured as described [36]. All experiments were
performed in the presence of L-NNA (100 mM) to eliminate the
possible contribution from nitrergic nerve activity.
Analysis of targeting microRNAs
Potential targeting miRNAs for 97 dysregulated SM genes and
58 dysregulated transcription regulators were retrieved and
analyzed from two well-established target prediction programs:
PicTar [37] and TargetScan (release 5.1) [38,39]. Genechip array
data (fold change and P value) and expression profiles (SM-
common, SM-unique, and non-SM miRNAs) were shown along
with PicTar and TargetScan miRNAs. Total hit miRNAs and
average miRNAs per gene in SM-common, SM-unique, and non-
SM miRNAs were calculated from PicTar and TargetScan
miRNAs.
Results
Phenotypic changes in the SMC-specific Dicer null mice
A previous study showed that loss of Dicer in vascular SMC
resulted in embryonic arrest and defective SMC contractile and
cytoskeletal organization [28]. We generated SMC-specific Dicer
null (smDicer
2/2;Cre-GFP/+)mice by cross breeding smMHC/Cre/
eGFP (smMHC
Cre-GFP/+) [31] and Dicer
lox/lox, in which mature
miRNAs were depleted in all SMCs. The smMHC
Cre-GFP/+ mice
express Cre recombinase and eGFP, which are directed by the SM
myosin heavy chain (Myh11) promoter and show SMC-specific
Cre/eGFP expression in SM organs [31]. All mice generated for
MiRNAs Remodel GI SMCs
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with a set of primers (see Table S1) specific for Cre, eGFP, inserted
lox P sites (lox), and for wild type (WT) or deleted locus (D)
(Figure 1A). Myh11 and Dicer transcripts were abundantly
expressed in the nine SM organ tissues from the WT mouse
(Figure 1B). Myh11-dependent knockout (KO, deletion) of Dicer
transcripts in the SM organ tissues from the smDicer
2/2;Cre-GFP/+
(smDicer mutant) mice resulted in partially deleted Dicer PCR
products (,150 bp) which were smaller than the WT (,400 bp)
(Figure 1C). We previously demonstrated small intestinal and
colonic SMCs sorted by FACS from smMHC
Cre-GFP/+ mice were a
pure population of differentiated SMCs [26]. The same FACS
technique was used to sort mutant (KO) SMCs from the smDicer
mutant mice along with WT SMCs from the WT controls. Sorted
KO SMCs were lacking WT Dicer PCR products which were
detected in WT SMCs, whereas they were partially deleted in SM
tissues where other cells would still express Dicer (Figure 1D),
confirming Dicer was completely deleted in KO SMCs. smDicer WT
and heterozygous mice showed no visible phenotypic changes
(Table 1). However, smDicer homozygous KO mice showed an
extreme GI phenotype and died at ,3 weeks of age. The smDicer
mutant mice were smaller and weighed 73% of its WT or
heterozygote siblings measured at 20–21 days (n=5). The average
length of the smDicer mutant small intestine (15.0 cm) and colon
(2.9 cm) was significantly shorter than the small intestines
(18.2 cm) and colons (4.0 cm) from the WT or heterozygote
siblings. However, the normalized length of the small intestine
(2.2 cm/g for KO and 2.0 cm/g for WT) and colon (0.4 cm/g for
KO and 0.4 cm/g for WT) by weight between the smDicer KO and
WT was similar, indicating the shorter small intestine and colon of
the smDicer KO was due to less body weight. The cecum was
significantly distended in the mutant while the antrum, small
intestine, and colon appeared to be partially distended (Figure 2B)
compared to those of the WT control mouse (Figure 2A). The
circular and longitudinal muscle layers of the smDicer mutant colon
(Figure 2D) were significantly atrophied, measuring only 44% of
the WT colon (Figure 2C). Inflammation of the villous lining
within the mucosal layer was also observed, characterized by
blunting and thickening of the villi (Figure 2F) when compared to
WT (Figure 2E). GFP expression and thickness of the muscularis
of the small intestine in the smDicer mutant mouse (Figure 2H)
when compared to WT (Figure 2G) were further confirmed using
both laser scanning confocal microscopy (LSCM) and differential
interference contrast (DIC) microscopy. The SM bundles of both
layers from the GI tracts (small intestine, cecum, and colon) of the
smDicer mutant were noticeably disorganized and underdeveloped
(Figure 2L–N) compared to those of the control mouse (Figure 2I–
K). The single SMC of the smDicer mutant appeared smaller and
abnormal (Figure 2Q and R) compared to the control (Figure 2O
and P). The morphological data obtained from SMCs would
suggest that there is a reduction in the number and size of cells,
which would lead to a thinner tunica muscularis in the smDicer
mutant mice.
Knockdown of SMC miRNAs in the smDicer mutant mice
Knockdown of SMC miRNAs in the smDicer mutants was
examined by qPCR. We previously cloned and identified a SM
miRNAome (312 miRNAs) from mouse small intestinal tissue
[26]. Extensive expression profiles of the SM miRNAome were
made by qPCR from the small intestine tissue and sorted SMCs
from the smDicer mutants and the wild type controls (see Table S2).
Among the 310 SM miRNAs screened by qPCR, 301 and 292
miRNAs were detected in the small intestinal tissue from the wild
type control and mutants, respectively (Table 2; details in Table
S2). However, expression levels of 268 miRNAs were reduced in
the mutant tissue with .2 folds compared to the wild type control
(Figure 3A). The 13% median value in the mutant tissue indicated
that 87% of the miRNA’s expression level was knocked down in
the mutant tissue, showing that expression levels of miRNAs were
dramatically reduced in the mutant SMCs (Table 2). qPCR
detected 275 in the wild type SMCs, but about half of the miRNAs
(136 miRNAs) were not detected in the mutant SMCs while 222
miRNAs showed reduction of expression level .2 fold (Figure 3B
and Table 2). The 0.1% median value in the mutant SMCs
indicated 99.9% of the miRNAs’ expression level was knocked
down in the mutant SMCs (Table 2). Among the 275 SMC
miRNAs, 136 miRNAs including miR-125a-5p and miR-29c(3p)
were completely abolished in the mutant SMCs. Expression levels
of miR-125a-5p and miR-29c(3p) were greatly reduced in the
mutant tissue, but were not detected in the mutant SMCs
(Figure 3C and Table S2). However, half of the SMC miRNAs
including miR-145(5p) and miR-143(3p) were still detected in the
mutant SMCs although expression levels of most of the SMC
miRNAs were significantly reduced in the SMCs (Figure 3C and
Table S2). This finding suggests that the 136 miRNAs abolished in
the mutant SMCs have a shorter life span in comparison to the
mature miRNAs, whereas the remaining miRNAs found in the
SMCs have a relatively longer life span. Interestingly, 26 miRNAs
Table 1. Summary of double transgenic mice generated in this study.
Genotype Total Male Female smDicer Phenotype
1 Dicer
+/+;smMHC
+/+ 7 3 4 Wild type Normal
2 Dicer
+/+;smMHC
Cre-GFP/+ 13 10 3 Wild type Normal
3 Dicer
lox/lox;smMHC
+/+ 7 3 4 Wild type Normal
4 Dicer
lox/+;smMHC
Cre-GFP/+ 8 4 4 Wild type Normal
5 Dicer
lox/+;smMHC
+/+ 27 11 16 Wild type Normal
6 Dicer
lox/D;smMHC
+/+ 10 10 0 Heterozygous null Normal
7* Dicer
lox/D;smMHC
Cre-GFP/+ 13 7 6 Homozygous null GI distension
8 Dicer
lox/D/+;smMHC
Cre-GFP/+ 23 13 10 Mixed Normal
9 Dicer
D/+;smMHC
+/+ 7 5 2 Heterozygous null Normal
10 Dicer
D/+;smMHC
Cre-GFP/+ 21 12 9 Heterozygous null Normal
Dicer
lox/D;smMHC
Cre-GFP/+ was renamed to smDicer
2/2;Cre-GFP/+.
doi:10.1371/journal.pone.0018628.t001
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in the mutant SMCs (Figure 3C, Table 2 and Table S2). These
miRNAs may be generated by Dicer-independent miRNA
biogenesis pathways such as Ago2 [40,41].
Functional changes in the tunica muscularis of the
smDicer mutant mice
Isometric force measurements of small intestinal and colonic
muscle tissues were performed to characterize functional changes
in the tunica muscularis of smDicer mutants compared to wild type
(WT) controls. Spontaneous activity was reduced in the small
intestines and colons from the mutant mice compared to those
from the WT control mice (Figure 4). In the small intestines from
the mutant mice, the amplitude of phasic contractions decreased
by approximately 23% (Figure 4B and F) compared to the WT
controls (Figure 4A and E). Colonic activity consisted of periodic
large amplitude phasic contractions occurring at ,3 cpm in WT
controls (Figure 4C and G) and mutant animals (Figure 4D and
H); however, phasic activity was less organized in mutant mice
compared to the controls. ACh (1 and 10 mM) enhanced
contractions of small intestinal and colonic muscles (Figure 4A
and C). Responses to cholinergic stimulation were greatly reduced
in mutant mice. Intestinal responses to cholinerigic stimulation
were reduced by 31% and 35% to exogenous ACh (Figure 4A and
B; 1 & 10 mM, respectively). Colonic responses were reduced by
49% to both 1 and 10 mM ACh (Figure 4C and D). Loss of
responsiveness to cholinergic stimulation was not simply due to
defects in this specific signaling pathway because contractions
elicited by membrane depolarization (e.g. exposure of muscles to
elevated extracellular [K
+]; 48 and 96 mM) were also reduced in
Figure 1. Genotyping and expression analysis of SMC-specific Dicer knockout mice. (A) Each mouse line was genotyped using PCR with a
set of primers specific for Cre, eGFP, inserted lox P sites (lox), and wild type (WT) or deleted locus (D). The smDicer homozygous knockout (KO)
smDicer
2/2;Cre-GFP/+ is indicated by an asterisk on the mouse line 7 (w). All genotypes for mouse lines 1–10 are shown in Table 1. (B) Myh11 and Dicer
transcripts abundantly expressed in the SM organ tissues from the WT mouse. Hmbs was used as an endogenous control. (C) Expression of Myh11
and Myh11-dependent KO (deletion) of Dicer transcripts in the SM organ tissues from the smDicer KO mouse. Note that the deleted Dicer PCR
products (,150 bp) are smaller than the WT (,400 bp). (D) Expression of Myh11 and Dicer transcripts in the small intestine SM tissue (SM) and cells
(SMCs) sorted by FACS. Dicer transcripts were completely deleted in the sorted SMCs from the smDicer KO mouse while they were partially deleted in
the SM. All PCR products were analyzed on 1.5% agarose gels along with a DNA ladder. NTC stands for non-template control, SM for smooth muscle
tissue, and SMC for smooth muscle cells.
doi:10.1371/journal.pone.0018628.g001
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Cre-GFP/+
(wild type) mouse (A) compared to a smDicer
2/2;Cre-GFP/+ (smDicer knockout) mouse (B) of the same age. Note the large, distended cecum as well as
the partially distended antrum, small intestine, and colon in the smDicer knockout mutant. (C, D) Representative digital photomicrographs of cryostat
sections from the colon of wild type control and mutant mice respectively (hematoxylin and eosin staining). (C) A wild type mouse shows
unremarkable histology through the entire thickness of the colonic wall. (D) A smDicer knockout mouse shows that both the circular (CM) and
longitudinal (LM) muscle layers of the colonic muscularis appear atrophied compared to the wild type mouse. Also noticeable is that the mucosal (M)
villi in the knockout mouse appear blunted, thickened, inflamed, and accompanied by a chronic inflammatory infiltrate. (E, F) Enlarged regions of C
and D showing that in the smDicer knockout section (F) villi are blunted, thickened, and inflamed (arrows), and that there are numerous cells
(arrowheads) constituting an inflammatory infiltrate indicative of chronic inflammation. (G, H) LSCM and DIC images of cryostat sections taken from
the small intestine of the control (G) and smDicer knockout (H) under UV. Note that both the CM and LM are much thinner in the knockout compared
to the controls. (I–N) LCSM images of the entire thickness of the muscularis of the control small intestine (I), cecum (J), and colon tissue (K) from the
MiRNAs Remodel GI SMCs
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96 mM external K
+, respectively) while colons of mutant mice by
57% and 29%; Figure 4G and H, 48 and 96 mM extracellular
[K
+], respectively).
SM genes and transcriptional regulators are dysregulated
in the smDicer mutant mice
SM gene expression in small intestinal SM was analyzed by
GeneChip microarrays. The microarrays yielded expression
profiles of ,39,000 transcripts from the smDicer KO and WT
control mice. The intestinal SM contains SMCs and several other
cells including interstitial cells of Cajal (ICC), nerve cells, glial cells,
fibroblasts, and cells of hematopoietic origin. To examine gene
changes in SMCs, we selected 540 previously identified SM genes
collected from the GenBank for further analysis. Data filtering
using a P-value cutoff of 0.05 in expression yielded 97 SM genes
which were expressed aberrantly in the smDicer KO mice in
comparison to the WT mice (Figure 5A). Among the dysregulated
SM genes, 36 were up-regulated while 61, including Srf, were
down-regulated in the smDicer KO mice (Figure 5A). Interestingly,
35 genes among the dysregulated genes are known to be SRF
target genes [12,42] (see Table S3). There are more SRF target
genes (26) among those down-regulated than those (9) up-
regulated. The seven genes, Pln, Ckm, Tln1, Mylk, Fhl2, Ldb2,
and Tns1, which were shown to be the most significantly reduced
in the smDicer KO mice, are all SRF target genes (see Table S3).
Gene Ontology (GO) annotation comparing up- and down-
regulated SM genes revealed that the two groups were different in
biological processes ascribed to each gene set (Figure 5B). Immune
system processes, cell killing/death, and multi-organism processes
were found only in the up-regulated SM genes but not in the
down-regulated, indicating that genes involved in these biological
processes are over-expressed in the smDicer KO SMCs. Converse-
ly, cellular process, catalytic activity, cellular component organi-
zation, anatomical structure formation, transcriptional regulator
activity, and structural molecule activity appeared only in the
down-regulated SM genes, indicating that genes involved in these
biological processes are missing or significantly down-regulated in
the smDicer KO SMCs (Figure 5B). In addition, binding, biological
regulation, and developmental processes were greatly increased in
the down-regulated SM genes, indicating that genes involved in
these biological processes are also greatly down-regulated in the
smDicer KO SMCs (Figure 5B).
Dysregulated genes were confirmed in SM tissue and SMCs
from the smDicer KO mice through qPCR. In the smDicer KO small
intestine tissues, 29 dysregulated genes, including 6 SRF target
genes (see Table S3) from the GeneChip data, matched qPCR
data (Figure 5C). Expression profiles of all 29 genes tested from the
smDicer KO tissues in comparison to the WT tissues were
consistent between the GeneChip array data and the qPCR data.
Furthermore, qPCR expression profiles of the 22 genes from the
smDicer KO SMCs and WT SMCs were consistent with the
GeneChip data (Figure 5C). Seven genes including Srf, Ckm, Mkl2,
Myl4, Smarca2, and Smarca4 were not detected in the smDicer KO
SMCs by qPCR (see Figure S1). In addition, expression profiles of
the 6 genes obtained by qPCR were much different in SMCs than
in tissues (Figure 5D). Capn3 was not detected in either smDicer KO
or WT SMCs. Cdkn1a, Fbln5, Vcam1, and Vnn1, which were up-
regulated in the smDicer KO tissue, were not detected in the smDicer
KO SMCs. Conversely, MapK7, which was down-regulated in the
smDicer KO tissue, was actually up-regulated in the smDicer KO
SMCs (Figure 5D). Taken together, this qPCR data showed that
all 6 SRF target genes (see Table S3) tested were abolished or
down-regulated in the smDicer KO SMCs. In addition, we
validated the reduction of two important proteins, SRF (the
master switch for SM contractile genes) and ACTA2 (SM a-actin,
a well-known marker for SMCs), in the KO small intestine and
colon tissues by Western blot. Consistent with the expression
profiles obtained from the microarray and qPCR results, SRF and
ACTA2 were significantly reduced by 90% and 40% respectively
in the KO tissues (Figure 5E).
We also analyzed miRNAs targeting 58 transcriptional regulators
that were dysregulated in the microarray from the smDicer KO mice.
Among the 58 regulator genes, 15 were up-regulated while 43 were
down-regulated in the smDicer KO SM (see Table S4). About half of
the genes are known to be positive (17), negative (12), or both positive
and negative (6) regulators during transcription in the GO categories.
Nineteen genes are involved in cell proliferation (8), differentiation
(18),orbothproliferationand differentiation(7) intheGOcategories.
Those involved in both show cell-specific proliferation, or differen-
tiation in different cell types. We examined the 19 regulatory genes
associated with cell proliferation and differentiation in small intestinal
SM tissues and SMCs from the smDicer WT and KO mice by PCR.
The WT SM tissue expressed 11 regulatory genes detected by PCR
while the smDicer KO SM tissue expressed 9 genes (see Figure S2 and
TableS4).TheWTSMCsexpressed6genes(Arnt, Hif1a,Id4,Nkx2-3,
Pgr,a n dZnrd1), but 4 genes (Barx2, Irx5, Neurod4, Pou3f1,a n dProx1)
were not detected by PCR. However, all of the 6 genes expressed in
the WT SMCs were abolished in the smDicer KO SMCs (see Figure
S2). The 6 regulatory genes are associated with cell proliferation (Pgr),
differentiation (Znrd1, Hif1a,a n dArnt), or both proliferation and
differentiation (Id4 and Nkx2-3)i nt h eG Oc a t e g o r i e s( s e eT a b l eS 4 ) .
knockout mouse. LCSM images of the entire thickness of the muscularis from the small intestine (L), cecum (M), and colon tissue (N) of the knockout
showing less well-differentiated SMC organization. (O–R) Fluorescence and contrast phase images of an isolated intestinal SMC from the control (O
and P) and knockout (Q and R). Note the disorganized and abnormal appearance of the circular and longitudinal SMCs from the knockouts compared
to the controls.
doi:10.1371/journal.pone.0018628.g002
Table 2. Summary of miRNAs knocked down in smDicer KO SM tissue and SMCs.
SM tissue Dysregulation in KO SMC Dysregulation in KO
WT KO Median Down Up WT KO Median KO Down Up
miRNAs 301 292 13% 268 4 275 139 0.1% 222 26
Up/down: .2 fold changes.
doi:10.1371/journal.pone.0018628.t002
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potential targets of SM miRNAs
To see if there was a link between the dysregulated SM genes in
the smDicer mutant mice and the SM miRNAome that we
previously cloned and identified from mouse small intestine [26],
we retrieved all putative targeting miRNAs using the 97
dysregulated SM genes from miRNA targeting databases PicTar
[37] and TargetScan [38,39] and analyzed how many miRNAs
among the targeting miRNAs were found in the SM miRNAome.
In the SM miRNAome, we previously grouped the cloned SM
miRNAs into two categories: SM common (found in mice and
humans) and SM unique miRNAs (found in either mice or
humans) [26]. Most targeting miRNAs retrieved from PicTar and
TargetScan (see Table S5) were found in the SM miRNAome
[26]. Average hit per miRNA from PicTar was significantly higher
(4 times higher compared to the non SM miRNAs) in SM
common miRNAs (0.59) than in SM unique (0.36) and in non SM
miRNAs (0.15) (see Table S5). A similar result was obtained from
TargetScan: 0.66 (5 times higher) in SM common, 0.21 in SM
unique, and 0.14 in non SM miRNAs (see Table S5).
We also analyzed miRNAs targeting 58 transcriptional
regulators that were dysregulated in the microarray from the
smDicer mutant mice. Among the 58 transcriptional regulators, 15
were up-regulated while 43 were down-regulated (see Table S6).
Both PicTar and TargetScan predicted most SM miRNAs (SM
common and SM unique) compared to non SM miRNAs. Average
hit per miRNA from PicTar was considerably higher (6 times
higher compared to the non SM miRNAs) in SM common
miRNAs (0.43) than in SM unique (0.22) and in non SM miRNAs
(0.07) (see Table S6). A similar result was obtained from
TargetScan: 0.62 (5 times higher) in SM common, 0.20 in SM
unique, and 0.12 in non SM miRNAs (see Table S6).
This miRNA targeting analysis shows there is a close link
between SM common miRNAs and the dysregulated SM genes or
transcriptional regulators, suggesting that SM common miRNAs
may target the dysregulated SM genes and transcriptional
regulators, leading to the phenotypic changes in the smDicer
mutant SMCs.
Discussion
The smDicer KO mice implicated in the regulation of SMC
phenotype by the SRF-dependent, SMC-phenotypic
miRNAs
In this study, we showed that specific KO of Dicer in SMCs
resulted in a dramatic phenotype in the GI tract. The smDicer
mutant mice showed significantly thinner longitudinal and circular
muscle layers as well as aberrant SMCs in the GI tract (Figure 2).
This mutant SMC phenotype is remarkably similar to that of the
inducible, SM-specific Srf null mice that developed severe dilation
Figure 3. Reduction of miRNAs in the smDicer knockout SMCs. The expression level of SMC miRNAs was examined in the small intestinal SM
and SMCs from the wild type (WT) control and smDicer knockout (KO) mice by qPCR. Expression levels for each miRNA were normalized by an average
expression level of the 5 snoRNA genes. Normalized expression levels were converted into a log scale and then plotted on the graph. (A) Knockdown
of miRNAs in the smDicer KO SM. (B) Knockdown of miRNAs in the smDicer KO SMCs. Note that 87% of the miRNA’s expression level was reduced in
the smDicer KO SM while 99% was reduced in the smDicer KO SMCs. (C) Representative gels of qPCR amplicons. miR-125a-5p, miR-29c(3p), miR-
145(5p), miR-143(3p), miR-337-5p, and miR-380-3p were analyzed on the gels. snoRNA U24 (Snorrd24) was employed as one of the 5 endogenous
genes used for the normalization.
doi:10.1371/journal.pone.0018628.g003
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PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18628Figure 4. Reduced small intestinal and colonic contractility in the smDicer knockout mutants compared to the wild type controls. (A–D)
The effects of ACh (1 & 10 mM) on the small intestines and colons of control (A, C) and mutant tissues (B, D) respectively (solid bars indicate the time
of exposure). (E–H) The effect of increasing extracellular [K
+] (48 & 96 mM) in small intestines and colons of control (E, G) and mutant tissues (F, H).
Experiments were preformed in the presence of L-NNA (100 mM) to reduce influences from inhibitory motor nerves. (n=3).
doi:10.1371/journal.pone.0018628.g004
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PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e18628of the intestinal tract associated with the thinning of muscle layers
[43,44]. We previously cloned and identified the intestinal SMC
miRNAomes from mice and humans, a large number of which are
regulated by SRF through CArG boxes found around the SMC
miRNA genes [26]. Our SMC-specific Dicer KO mice, along with
the Srf null mice, confirmed that SMC phenotype is modulated, in
part, via the SRF-dependent, SMC miRNAs through the SMC
miRNA CArG boxes.
The mutant SMC phenotype and human intestinal
obstruction
The extensively dilated intestinal tract associated with impaired
SMCs shown in Figure 2 is a typical feature of congenital MMIHS
[30] or CIPO [29]. MMIHS is a congenital form of CIPO that
causes functional neonatal intestinal obstruction. MMIHS occurs
in the GI tract and urinary bladder, and is the most severe form of
functional intestinal obstruction in newborns [45]. The cellular
and molecular mechanisms underlying this disorder are largely
unknown. The major feature of this congenital and usually lethal
anomaly is abdominal distension caused by degenerative SMCs
[46]. Contractile SM genes were down-regulated in the mutant
SMCs (Figure 5A and C), similar to alterations found in MMIHS
[47] and the CIPO model mice [44]. Expressions of SM a-actin
(Acta2 in mice), calponin (Cnn1), caldesmon (Cald1), and desmin
(Des) that were significantly reduced in MMIHS [47,48] were also
reduced in the mutant SM tissue and isolated SMCs (Figure 5C, E
and Figure S1). In addition, reduction of SRF (Srf in mice) and
smoothelin-A (Smtnl1) found in CIPO [43,44,49] is also seen in the
mutant SM and/or SMCs (for Srf, see Figure 5C, E and Figure S1;
for Smtnl1, see the NCBI GEO array dataset GSE21738 deposited
in this study). This similarity suggests that the smDicer mutant mice
may be a model that could be useful in studies of MMIHS or
CIPO, and that MMIHS or CIPO is possibly linked to the
defective expression or function of SRF-dependent SMC miRNAs.
Affected miRNAs from the disruption of Dicer in SMCs
miRNAs affected in several different cell- or tissue-specific Dicer
KO animals are quite different. Abolished miRNAs depend on the
cell type, location, and time when Dicer is disrupted during the
development of the cells. miRNA biogenesis is primarily regulated
at the level of gene transcription [50]. Although some transcrip-
tional factors (e.g. HIF1a, MYC, NF-kB, c-Jun, and p53) have
been found to regulate the promoter activity of miRNAs [51–54],
transcriptional regulation of miRNAs are complicated and largely
unknown. miRNAs are generated from intergenic regions
[probably non-coding RNAs (ncRNAs)], introns, and exons (59
or 39 UTR, and CDS). What’s even more complicated is the fact
that some miRNAs are generated from the antisense of introns and
exons. We analyzed SM miRNA transcriptomes that we
previously cloned and identified from humans and mice [26]. In
mouse miRNAs, 48% of the miRNAs originated from mRNAs,
42% were from known transcripts, and 10% were from ncRNAs.
In human miRNAs, 57% of the miRNAs originated from mRNAs,
30% were from unknown transcripts, and 13% were from
ncRNAs. Half (50%) of the mouse miRNAs were located within
intergenic regions, 41% in introns, and 1% in exons. Interestingly,
8% of the miRNAs were located in either antisense strand of
introns or exons, suggesting they are transcribed by their own anti-
directional promoters. The origin of human miRNAs showed a
similar distribution: 43% in intergenic regions, 48% in introns, 2%
in exons, and 7% in antisense-introns. This heterogeneous origin
of miRNAs suggests each group of miRNAs with the same origin
may be generated and maintained in a different transcriptional
pathway. In this study, we demonstrated the expression of SM
miRNAs was reduced by 87% in the KO SMCs: 136 miRNAs
were not detectable, 222 miRNAs were reduced with .2 fold, and
26 miRNAs including miR-451 were upregulated with .2 fold
(Table 2; details in Table S2). Most SM miRNAs were
downregulated and Dicer-dependent. However, the differential
reduction data suggests that mature miRNAs are differentially
reduced and disappear in the developing SMCs after ablation of
Dicer at E12.5 days when Cre is activated in the cells [31].
Differential reduction of miRNAs is consistent in other Dicer KO
mice [8,55]. This differential reduction of miRNAs in the KO cells
may be due to different turnover and stability rates for each
miRNA in multiple biogenesis pathways in different tissues
[56,57]. The 26 upregulated miRNAs identified in this study are
also of interest because they may be generated by multiple Dicer-
independent pathways. Recent studies showed that miR-451 is
indeed processed by Dicer-independent Ago2 [40,41]. It would be
interesting to see if the other upregulated miRNAs are processed
by Ago2 or by other Argonaute proteins.
EGFP specifically expressed in the SMCs as a powerful
tool to study GI pathology
We generated SMC-specific Dicer null mice that expressed
eGFP in a SMC-specific manner (Figure 2). It is critical to purify
SMCs from other cells in order to study the changes in gene
expression specific to SMCs. GI SM, like other tissues, contains a
heterogeneous population of cells. Currently, there are no known
specific surface antigens for SMCs that can be used as a strategy
for isolating these cells via FACS. We circumvented this problem
by using the expression of eGFP which was directed to specific
SMC expression via the MHC promoter (smMHC
Cre-GFP/+) mice
[31]. We previously showed intestinal SMCs sorted from the mice
were differentiated SMCs [26]. These mice display bright green
fluorescence in all of the SMCs in the GI tract and also express
Cre recombinase in SMCs. We crossed these mice with a mouse
we bred (Dicer
lox/lox) to generate SMC-specific Dicer null offspring.
Figure 5. Expression profiles of dysregulated SM genes from the smDicer knockout SM tissues and SMCs. (A) Gene expression data was
obtained using Affymetrix GeneChip Mouse Genome 430 2.0 Array on small RNAs isolated from the small intestinal muscularis of 20-day old wild type
(WT) and smDicer knockout (KO) mice (n=2). Among ,39,000 transcripts, 540 previously known SM genes were chosen for further analysis. Data was
filtered using a P-value cutoff of 0.05 for expression and for the same + or 2 values in the two samples resulting in 97 SM genes (36 upregulated and
61 down-regulated). Clustering dendrograms show the relative expression values according to the following coloring scheme: red=high,
white=moderate, green=low. (B) Comparison of GO annotation in up- and down-regulated SM genes. (C) To confirm the expression profiles from
the array, qPCR was performed on cDNAs made from the WT and KO small intestinal SM tissues and SMCs. The expression level of each gene was
normalized by an average Ct value of Gapdh and Actb. Since the WT tissue expressed all the genes tested, the normalized value of the control genes
was further normalized by that of the WT tissue. On the heat map, the WT tissue genes were set up as 5 (black) in a range of 0 (lowest) to 10 (highest),
and genes of the KO tissue, WT, and KO SMC were expressed relative to that of the WT. GeneChip fold changes are shown along with the gene
names. (D) Confirmation of qPCR products showing the discrepancy between the tissues and SMCs was analyzed on 2% agarose gels. (E) Western
blot analysis showing reduction of SRF and SM a-actin (ACTA2) in the smDicer KO small intestine and colon. Expression level of each protein was
normalized by GAPDH.
doi:10.1371/journal.pone.0018628.g005
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structure of the tunica muscularis via confocal microscopy, FACS,
and purification of SMCs for the analysis of gene expression. This
transgenic model using SMC-specific eGFP expression provides a
powerful new tool to study the function and genetic regulation of
SMC phenotypes that may be altered as a result of MMIHS or
CIPO.
Inflammatory infiltrate in the smDicer KO colon
We observed atrophy of both the circular and longitudinal
muscle layers in the colonic muscularis (Figure 2D). The colonic
mucosal layer exhibited inflammation accompanied by an
extensive inflammatory infiltrate correlating to the onset of colitis
[58] (Figure 2F). It would appear that the inflammatory cell
infiltrate is most notable in the lamina propria, submucosa, and
muscularis mucosa regions. The predominant cells comprising the
inflammatory infiltrate in the dextran sulphate sodium (DSS)–
induced colitis animal model are macrophages, neutrophils, and
eosinophils [58]. These cell types may be responsible for the
extensive inflammatory infiltrate evident in Figure 2F, but in order
to precisely identify these cell types, immunohistochemistry would
be required. Another notable observation in the inflamed colon
from the smDicer KO mice is that many cells within the mucosal
lining appear apoptotic although confirmation by TUNEL is
required for verification. The inflammatory infiltrate might be
responsible for the increased expression of the genes involved in
immune system processes and cell killing/death in the smDicer KO
mice (Figure 5B). In addition, GI SMCs from patients with
ulcerative colitis, an idiopathic inflammatory disease of the colon,
showed an abnormal motor dysfunction in the colonic circular
muscle while the muscularis propria contained increased pro-
inflammatory cytokine signals [59]. These observations in the
colonic colitis are similar to the abnormalities (inflammatory
infiltrate, increased immune system and apoptotic activities, and
reduced contractility) in the inflamed colon obtained from the
smDicer KO mice in this study. Taken together, our data suggest
that the abnormal SMCs may trigger inflammatory infiltrate while
normal SMCs should have some mechanisms to suppress or
bypass the pro-inflammatory cytokine signals.
A Network of interaction among SRF, SM miRNAs,
transcriptional factors, and SM genes
We showed that aberrantly expressed SM genes and transcrip-
tional regulators are potential targets of SM miRNAs (see Tables S5
and S6). Collectively, our studies regarding the SM miRNAome
analyzed with the miRNA expression and targeting analyses lead us
to propose a model that SM genes are regulated by multiple
pathways to control SMC growth and differentiation (Figure 6).
Expression of SM genes is affected by positive and negative
regulation in a network of SM miRNAs, SRF, and transcriptional
factors. SM miRNAs negatively regulate SRF, SM genes, and
transcriptional factors at the post-transcriptional level by binding to
their target transcripts. Transcriptional factors positively or
negatively regulate SRF and SM genes at the transcriptional level
by binding to their regulatory sites, while SRF positively regulates
SM miRNAs, SM genes, and SRF itself at the transcriptional level
by binding to their CArG or CArG-like boxes. This model presents
a network of interaction among SRF, SM miRNAs, transcriptional
factors, and SM genes and offers the unique opportunity to study
theregulationoftheSMCphenotypeinotherpathologicalcontexts.
Supporting Information
Text S1 Extended Materials and Methods.
(DOC)
Figure S1 Confirmation of qPCR products showing the
discrepancy between the smooth muscle tissues and
sorted SMCs from the wild type control and the smDicer
knockout mice. qPCR products from Figure 5C were analyzed
on 2% agarose gels. Actb was used as an endogenous control.
(TIF)
Figure S2 Expression of 11 transcriptional regulators in
the smooth muscle tissues and sorted SMCs from the
wild type control and the smDicer knockout mice. PCR
products were analyzed on 2% agarose gels. Actb was used as an
endogenous control.
(TIF)
Table S1 Oligonucleotides used in this study.
(DOC)
Table S2 Reduction of miRNAs in small intestine tissue and
SMCs from the smDicer knockout mice.
(XIS)
Table S3 A list of SM genes dysregulated in the smDicer
knockout mice.
(XIS)
Table S4 A list of transcriptional regulators dysregulated in the
smDicer knockout mice.
(XIS)
Figure 6. Model of the regulation of SM genes by SM miRNAs,
SRF, and transcriptional factors. SM genes are regulated by
multiple pathways that fine tune SMC growth and differentiation. 1)
SM genes are directly and positively regulated by SRF; SM genes are SRF
targets that are transcriptionally turned on by SRF [15]. 2) SM genes are
directly and negatively affected by SM miRNAs; SM miRNAs target SM
genes (see Table S5). 3) SM genes are indirectly and negatively
controlled by SRF through SM miRNAs; we previously found that a large
number of SM miRNAs, such as miR-143/miR-145 and miR-199a/miR-
214, are SRF targets [26], and SM miRNAs target SM genes (see Table
S5). 4) SM genes are directly and positively/negatively affected by
transcriptional factors; in the smDicer-GFP mice, transcriptional factors
up or down-regulated are positive and/or negative regulators of
transcription for SM genes (see Table S4). 5) SM genes are indirectly and
positively/negatively controlled by SM miRNAs through transcriptional
factors; transcriptional factors are potential SM miRNA targets (see
Table S6) and repressed transcriptional factors regulate the expression
of SM genes. 6) SM genes are indirectly and positively/negatively
affected by SRF through SM miRNAs and transcriptional factors; SRF
turns on SRF-dependent SM miRNAs, which target transcriptional
factors. Repressed transcriptional factors regulate the expression of SM
genes.
doi:10.1371/journal.pone.0018628.g006
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